In this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies and innovative medication.
This offering includes a broad range of enabling technologies and extensive global facilities including R&D centres located in Devens, Massachusetts and Cambridge, UK as well as manufacturing sites in West Deptford, New Jersey; Conshohocken, Philadelphia; North Andover, Massachusetts; and Annan, Scotland. In addition to the existing offer, Nicholas will be responsible for growing the capabilities through addition of new technologies and assets to service the expanding market for technology-enabled custom development and manufacturing solutions.
Nicholas brings a wealth of experience to JM, having most recently held the positon of Senior Vice President at Aceto Corporation where he was responsible for the pharmaceutical ingredients businesses. Prior to this he has had senior positions at BASF, Cambrex and Avecia and holds a BEng from Imperial College, London.
"We are excited to have Nicholas join our Health sector in this critical position," commented Robert MacLeod, Chief Executive of JM. "His extensive knowledge of the pharmaceutical innovator market coupled with his senior leadership skills will be invaluable in driving our strategic growth-providing solutions to the clinical development and commercial manufacturing needs of the pharma and biotech industries."